Details of Drug Off-Target (DOT)
General Information of Drug Off-Target (DOT) (ID: OTXOSGIB)
| DOT Name | NKG2-F type II integral membrane protein (KLRC4) | ||||
|---|---|---|---|---|---|
| Synonyms | NK cell receptor F; NKG2-F-activating NK receptor | ||||
| Gene Name | KLRC4 | ||||
| Related Disease | |||||
| UniProt ID | |||||
| 3D Structure | |||||
| Sequence |
MNKQRGTYSEVSLAQDPKRQQRKLKGNKISISGTKQEIFQVELNLQNASSDHQGNDKTYH
CKGLLPPPEKLTAEVLGIICIVLMATVLKTIVLIPCIGVLEQNNFSLNRRMQKARHCGHC PEEWITYSNSCYYIGKERRTWEERVCWPVLRRTLICFL |
||||
| Function | May play a role as a receptor for the recognition of MHC class I HLA-E molecules by NK cells. | ||||
| Tissue Specificity | Natural killer cells. | ||||
| KEGG Pathway | |||||
Molecular Interaction Atlas (MIA) of This DOT
|
3 Disease(s) Related to This DOT
|
||||||||||||||||||||||||||||||||||||
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 Drug(s) Affected the Post-Translational Modifications of This DOT
|
||||||||||||||||||||||||||||||||||||
|
1 Drug(s) Affected the Gene/Protein Processing of This DOT
|
||||||||||||||||||||||||||||||||||||
References
